검색
Home
National
All
Politics
Social Affairs
Foreign Affairs
Defense
North Korea
Diplomatic Circuit
K-Wellness
Business
All
Industry
Technology
Mobility
Economy
Market
Life&Culture
All
Culture
Travel
Food
Books
People
Arts & Design
Film
Television
Performance
Sports
All
Soccer
Baseball
Golf
More Sports
World
All
World News
World Business
Opinion
All
Editorial
Viewpoints
K-pop
한국어판
More +
Weekender
English Eye
Podcast
Interactive
PR newswire
Global insight
Send E-mail
Exicon participates in paid-in capital increase of Sam CNS
Exicon (092870) said on July 4 that it bought 14 million shares, or 38.89 percent stakes, in Sam CNS, a Korean ceramic base material manufacturer, in a bid to secure a new growth engine by entering the materials business.
From
Send to
Close
Send
Link copied
11:50
Stray Kids perform new single, ‘Lose My Breath,’ on GMA
10:42
Vintage digicams sought again by '90s kids
10:40
NASA officials upbeat about greater space cooperation with S. Korea
09:51
Job additions rebound to over 200,000 in April amid rising exports
09:31
Seoul shares start tad lower on profit taking
09:19
N. Korea slams planned S. Korea-US military drills, warns of 'catastrophic aftermath'
09:01
[Well-curated] Luck of the draw
09:01
[Box office] Movies in theaters this week
09:01
[Around the hotels] Promotions and packages
09:01
[Travel Bits] Festivals, sights across Korea
Exicon participates in paid-in capital increase of Sam CNS
July 4, 2016 - 14:45
By 박한나
[DISCLOSURE]
Exicon
(092870) said on July 4 that it bought 14 million shares, or 38.89 percent stakes, in Sam CNS, a Korean ceramic base material manufacturer, in a bid to secure a new growth engine by entering the materials business.
박한나
Most Popular
1
Do Korean doctors make too much money?
2
Korean industries gauge impact of Biden's steep tariffs on China
3
Court refuses injunction on medical school expansion
4
Why Korean crime stories typically feature nameless, faceless perpetrators
5
Is FTC's conglomerate listing a boon or bane for Hybe?
6
NewJeans to headline palace show